Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Time Vested Restricted Stock

The table below presents the time vested restricted stock awarded to senior officers, directors and certain employees.

	As of December 31, 2025
Date of award	Number of shares	Number of Officers, Directors and Employees
February 2025	204,164	129
March 2025	4,507	2
May 2025	2,597	1
July 2025	476	1

Schedule of Unvested Restricted Stock Awards

The table below summarizes the unvested restricted stock awards for performance.

	For the Year Ended December 31,
	2025			2024			2023
Performance Awards	Shares	Weighted Average Grant Date  Fair Value		Shares	Weighted Average Grant Date  Fair Value		Shares	Weighted Average Grant Date  Fair Value
Unvested at beginning	226,479	$	27.53	123,215	$	44.74	129,855	$	45.15
Granted	147,702	18.19		150,570	18.47		71,003	40.50
Forfeited	(33,035)	48.66		(28,826)	40.96		(44,084)	40.29
Vested	—	—		(18,480)	47.57		(33,559)	44.60
Unvested at end	341,146	$	21.44	226,479	$	27.53	123,215	$	44.74

The following table summarizes the unvested time vesting restricted stock awards.

	For the Year Ended December 31,
	2025			2024			2023
Time Vested Awards - RSA	Shares	Weighted Average Grant Date  Fair Value		Shares	Weighted Average Grant Date  Fair Value		Shares	Weighted Average Grant Date  Fair Value
Unvested at beginning	430,305	$	31.35	313,992	$	49.08	302,148	$	53.75
Granted	211,744	23.20		312,368	23.22		190,256	44.16
Forfeited	(25,086)	24.86		(38,772)	36.18		(27,558)	51.57
Vested	(247,640)	32.81		(157,283)	49.41		(150,854)	51.76
Unvested at end	369,323	$	26.14	430,305	$	31.35	313,992	$	49.08

Schedule of Activity of Stock Options

The table below is a summary of stock option activity. The information excludes restricted stock units and awards.

	For the Year Ended December 31,
	2025				2024				2023
Time Vested Awards - Options	Shares	Weighted Average Exercise  Price		Weighted Average Remaining Contractual Term	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Shares	Weighted Average Exercise  Price		Weighted Average Remaining Contractual Term
Beginning balance	2,500	$	47.95	5.02	2,500	$	47.95	6.02	2,500	$	47.95	7.02
Granted	133,401	22.76		9.16	—	—		—	—	—		—
Exercised	—	—		—	—	—		—	—	—		—
Forfeited	—	—		—	—	—		—	—	—		—
Ending balance	135,901	$	23.22	9.07	2,500	$	47.95	5.02	2,500	$	47.95	6.02
Exercisable end of year	2,500	$	47.95	4.02	2,500	$	47.95	5.02	2,500	$	47.95	6.02

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

	For the Year Ended December 31,
	2025		2024	2023
Risk-free interest rate	4.09	%	N/A	N/A
Expected term in years	6.44		N/A	N/A
Expected stock price volatility	43.94	%	N/A	N/A
Dividend yield	2.90	%	N/A	N/A